J.L. Bainbridge & Co’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.23K | Hold |
11,121
| – | – | ﹤0.01% | 101 |
|
|
2025
Q1 | $7.48K | Hold |
11,121
| – | – | ﹤0.01% | 97 |
|
|
2024
Q4 | $10.5K | Hold |
11,121
| – | – | ﹤0.01% | 100 |
|
|
2024
Q3 | $16.9K | Hold |
11,121
| – | – | ﹤0.01% | 100 |
|
|
2024
Q2 | $13.2K | Hold |
11,121
| – | – | ﹤0.01% | 88 |
|
|
2024
Q1 | $20K | Hold |
11,121
| – | – | ﹤0.01% | 89 |
|
|
2023
Q4 | $9.79K | Hold |
11,121
| – | – | ﹤0.01% | 83 |
|
|
2023
Q3 | $8.19K | Buy |
11,121
+500
| +5% | +$368 | ﹤0.01% | 77 |
|
|
2023
Q2 | $13.4K | Hold |
10,621
| – | – | ﹤0.01% | 76 |
|
|
2023
Q1 | $7.7K | Hold |
10,621
| – | – | ﹤0.01% | 72 |
|
|
2022
Q4 | $5.61K | Hold |
10,621
| – | – | ﹤0.01% | 73 |
|
|
2022
Q3 | $9K | Hold |
10,621
| – | – | ﹤0.01% | 66 |
|
|
2022
Q2 | $12K | Hold |
10,621
| – | – | ﹤0.01% | 71 |
|
|
2022
Q1 | $13K | Hold |
10,621
| – | – | ﹤0.01% | 82 |
|
|
2021
Q4 | $17K | Hold |
10,621
| – | – | ﹤0.01% | 83 |
|
|
2021
Q3 | $35K | Hold |
10,621
| – | – | ﹤0.01% | 86 |
|
|
2021
Q2 | $67K | Buy |
+10,621
| New | +$67K | 0.01% | 84 |
|